Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Rucaparib and olaparib for the treatment of prostate cancer: A clinician's guide to choice of therapy.

Keisner SV. Rucaparib and olaparib for the treatment of prostate cancer: A clinician's guide to choice of therapy. J Oncol Pharm Pract. 2022 Oct; 28(7):1624-1633.

View in: PubMed

collapse authors with profiles